Citations

Mayo Clinic

Clear

12581 citation(s) found for "Wu, John".

Functional analysis of the C-terminal boundary of the second nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator and structural implications
Gentzsch, Martina , Aleksandrov, Andrei A. , Aleksandrov, Luba A., Riordan, John R.

Biochemical Journal | September 20, 2002 | Volume: 366 | Issue: 2 | Pages: 541-548

10.1042/bj20020511 | PMID 12020354 Get It

The cystic fibrosis transmembrane conductance regulator (CFTR) contains two nucleotide-binding domains (NBDs) or ATP-binding cassettes (ABCs) that characterize a large family of membrane transporters. Although the three-dimensional structures of these domains from several ABC proteins have been determined, this is not the case for CFTR, and hence the domains are defined simply on the basis of sequence alignment. The functional C-terminal boundary of NBD1 of CFTR was located by analysis of chloride channel function [Chan, Csanady, Seto-Young, Nairn and Gadsby (2000) J. Gen. Physiol. 116, 163–180]. However, the boundary between the C-terminal end of NBD2 and sequences further downstream in the whole protein, that are important for its cellular localization and endocytotic turnover, has not been defined. We have now done this by assaying the influence of progressive C-terminal truncations on photolabelling of NBD2 by 8-azido-ATP, which reflects hydrolysis, as well as binding, at that domain, and on NBD2-dependent channel gating itself. The boundary defined in this way is between residues 1420 and 1424, which corresponds to the final β-strand in aligned NBDs whose structures have been determined. Utilization of this information should facilitate the generation of monodisperse NBD2 polypeptides for structural analysis, which until now has not been possible. The established boundary includes within NBD2 a hydrophobic patch of four residues (1413–1416) previously shown to be essential for CFTR maturation and stability [Gentzsch and Riordan (2001) J. Biol. Chem. 276, 1291–1298]. This hydrophobic cluster is conserved in most ABC proteins, and on alignment with ones of known structure constitutes the penultimate β-strand of the domain which is likely to participate in essential structure-stabilizing β-sheet formation.
Randomized Comparison of Low-Dose Involved-Field Radiotherapy and No Radiotherapy for Children With Hodgkin’s Disease Who Achieve a Complete Response to Chemotherapy
Nachman, James B., Sposto, Richard , Herzog, P, Gilchrist, Gerald S., Thomson, John W., Pattengale, Paul K., Davis, P, Hutchinson, Raymond J. , White, Keith S., Wolden, Suzanne L. , Kadin, Marshall E.

Journal of Clinical Oncology | September 12, 2002 | Volume: 20 | Issue: 18 | Pages: 3765-3771

10.1200/jco.2002.12.007 | PMID 12228196 Get It

PURPOSE: Current standard therapy for children and adolescents with Hodgkin’s disease includes combination chemotherapy and low-dose involved-field radiation (LD-IFRT). Because radiation may be associated with adverse late effects, the Children’s Cancer Group (CCG) investigated whether radiation could be omitted in patients achieving a complete response to initial chemotherapy without jeopardizing the excellent outcome obtained with combined-modality therapy. PATIENTS AND METHODS: Between January 1995 and December 1998, 829 eligible patients were enrolled onto CCG 5942. A total of 501 patients who achieved an initial complete response after risk-adapted combination chemotherapy were randomized to receive LD-IFRT or no further treatment. Event-free survival (EFS) and overall survival were assessed from the date of study entry or the date of randomization, as appropriate. RESULTS: The projected 3-year EFS from study entry for the entire cohort was 87% ± 1.2%. Among patients who achieved a complete response to initial chemotherapy, 92% ± 1.9% of those randomized to receive LD-IFRT were alive and disease free 3 years after randomization, versus 87% ± 2.2% for patients randomized to receive no further therapy (stratified log-rank test; P = .057). With an “as-treated” analysis, 3-year EFS after randomization for the radiation cohort was 93% ± 1.7% versus 85% ± 2.3% for patients receiving no further therapy (stratified log-rank test; P = .0024). Three-year survival estimates for patients treated with and without LD-IFRT were 98% ± 1.1% for patients who received radiation and 99% ± 0.5% for patients who did not receive radiation. CONCLUSION: LD-IFRT after an initial complete response to risk-adapted chemotherapy improved EFS. At this time, there is no survival advantage for LD-IFRT, but follow-up remains short.
Preimplantation genetic diagnosis of compound heterozygous mutations leading to ablation of plakophilin‐1 (PKP1) and resulting in skin fragility ectodermal dysplasia syndrome: a case report
Thornhill, Alan R., Pickering, Susan J., Whittock, Neil V., Caller, Jenny, Andritsos, Vicky, Bickerstaff, Helen, Handyside, Alan H. , Eady, Robin A.J., Braude, Peter, McGrath, John A.

Prenatal Diagnosis | September 11, 2002 | Volume: 20 | Issue: 13 | Pages: 1055-1062

10.1002/1097-0223(200012)20:13<1055::aid-pd978>3.0.co;2-# | PMID 11180229 Get It

Purification and Characterization of Two Polymorphic Variants of Short Chain Acyl-CoA Dehydrogenase Reveal Reduction of Catalytic Activity and Stability of the Gly185Ser Enzyme
Nguyen, Tien V., Riggs, Charles E., Babovic‐Vuksanovic, Dusica , Kim, Yong‐Sung , Carpenter, John F. , Gregersen, Niels , Vockley, Jerry , Nguyen, Tien V., Burghardt, Thomas P.

Biochemistry | September 10, 2002 | Volume: 41 | Issue: 37 | Pages: 11126-11133

10.1021/bi026030r | PMID 12220177 Get It

Aortic Root Dilatation After Repair of Tetralogy of Fallot
Warnes, Carole A. , Child, John

Circulation | September 10, 2002 | Volume: 106 | Issue: 11 | Pages: 1310-1311

10.1161/01.cir.0000032580.69198.a5 | PMID 12221044 Get It

Effectiveness of Thyroid Hormone Suppressive Therapy in Benign Solitary Thyroid Nodules: A Meta-Analysis
Castro, M. Regina , Caraballo, Pedro J. , Morris, John C.

The Journal of Clinical Endocrinology & Metabolism | September 5, 2002 | Volume: 87 | Issue: 9 | Pages: 4154-4159

10.1210/jc.2001-011762 | PMID 12213864 Get It

Thyroid Cancer in Patients with Familial Adenomatous Polyposis
Heerden, Jon A. van, Goellner, John R., Williams, E. D. , Gharib, Hossein, Marchesa, Pierenico, Fazio, Victor W., Perrier, Nancy D. , Church, James M. , Larson, Dirk R.

World Journal of Surgery | August 25, 2002 | Volume: 22 | Issue: 7 | Pages: 738-743

10.1007/s002689900462 | PMID 9606291 Get It

AbstractThe association between thyroid cancer and familial adenomatous polyposis (FAP), albeit rare, is well known. It has been suggested that the thyroid tumors have unique histologic characteristics and may be follicular in origin. Because of their rarity, treatment and long‐term prognosis are uncertain. Twelve such patients (prevalence 399/100,000) seen during 1949–1995 were retrospectively reviewed. Histology was independently re‐reviewed by two pathologists. There were 11 female patients (two sisters) and 1 male patient, with a mean age of 28 years (range 15–61 years). Eight patients (66%) had multicentric tumors and five (42%) bilateral disease. Average tumor diameter was 1.8 cm (range 0.2–5.0 cm). Regional nodal metastases were present in two patients. All 12 thyroid cancers in this series were papillary. The one male patient demonstrated “typical” histology with variable papillary and follicular architecture, whereas the 11 female patients had tumors with unusual histology as described by Harach. Five patients (41%) were treated by total thyroidectomy, five with near‐total thyroidectomy, and two with lobectomy alone. Mean follow‐up was 142 months (range 7 months to 30 years). Regional recurrent disease occurred in two patients, one of whom died of the disease. The 5‐ and 20‐year survivals were 90% and 77%, respectively. The results indicated that all tumors in this study were papillary, although atypical histology was encountered in 91%. The mean age (28 years) is younger than that of patients with sporadic disease. Multicentricity and bilateral disease are common. In view of this finding, total thyroidectomy should be strongly considered. Long‐term prognosis is excellent. The finding of unusual histology in a young patient with papillary thyroid carcinoma should arouse the suspicion of FAP.
Laparoscopic versus Open Posterior Adrenalectomy: Comparison of Acute‐phase Response and Wound Healing in the Cushingoid Porcine Model
Kollmorgen, Christine F., Thompson, Geoffrey B. , Grant, Clive S., Heerden, Jon A. van, Byrne, John, Davies, Edward T., Donohue, John H., Ilstrup, Duane M., Young, William F.

World Journal of Surgery | August 25, 2002 | Volume: 22 | Issue: 6 | Pages: 613-620

10.1007/s002689900443 | PMID 9597937 Get It

AbstractThis prospective randomized study examined the acute‐phase response and wound healing, comparing laparoscopic (LA) and open posterior (PA) adrenalectomy in a cushingoid porcine model. Repository corticotropin gel was given to 40 pigs for 21 days. Biochemical and tissue parameters of Cushing syndrome were confirmed. The pigs were randomized to undergo LA or PA. In addition to operating time and morbidity, the acute‐phase response was compared by measuring the postoperative white blood cell count, fasting glucose, C‐reactive protein, and nitrogen balance. Wound healing was assessed by (1) scored (1–4) gross appearance at 48 hours and 1 and 2 weeks; (2) histologic examination; and (3) tensile strength. There was no difference in operating time (mean ± SD) (36 ± 9 minutes open vs. 37 ± 7 minutes laparoscopic), perioperative mortality, degree of leukocytosis, fasting glucose, or C‐reactive protein (p > 0.05). Nitrogen balance, wound scores, and tensile strength at 24 hours and 1 week were more favorable in the LA group than in the PA group (p < 0.05). In the cushingoid porcine model, laparoscopic adrenalectomy was less catabolic and was associated with fewer wound complications than the open posterior adrenalectomy. These findings provide support for continued pursuit of laparoscopic methods for adrenalectomy in the clinical setting.
Previously undescribed syndrome of spondylometaphyseal dysplasia, osteocartilaginous metaplasia of long bones, and progressive osteolysis of distal phalanges
Osebold, William R., Poznanski, Andrew K., Opitz, John M. , Langer, Leonard O., Spranger, J�rgen W., Unni, K. Krishnan, Spranger, Jürgen W.

American Journal of Medical Genetics | August 25, 2002 | Volume: 80 | Issue: 3 | Pages: 187-195

10.1002/(sici)1096-8628(19981116)80:3<187::aid-ajmg1>3.0.co;2-# | PMID 9843035 Get It